Annual EBITDA
-$183.47M$190.33M+50.92%
Summary
- Current Value
- As of today, NVAX annual EBITDA is -$183.47M, up +50.92% on
- Historical Performance
- NVAX annual EBITDA is up +89.04% over the past 3 years, and down -48.21% over the past 5 years
- All-Time High Comparison
- NVAX annual EBITDA is currently -4285.13% below its historical high of -$4.18M set on
- 3-Year Low Comparison
- NVAX annual EBITDA is +70.20% above its 3-year low of -$615.68M reached on an earlier date
- Sector Comparison
- NVAX annual EBITDA is higher than 9.00% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$183.47M | +50.9% | +89.0% | -48.2% | -407.0% | |
| Quarterly EBITDA | -$72.82M | +37.8% | +38.7% | +62.1% | -615.2% | |
| TTM EBITDA | $451.74M | +285.8% | +137.6% | +276.5% | +1119.1% | |
| Price | $7.78 | -9.0% | -36.7% | -93.9% | -84.5% | |
| PE Ratio | 4.40 | – | – | – | – | |
| Annual Revenue | $682.16M | -30.6% | -40.5% | +3555.3% | +10000.0% | |
| Annual EPS | -$1.23 | +77.2% | +94.7% | +77.6% | +86.3% | |
| Annual EBIT | -$231.97M | +44.1% | +86.3% | -79.0% | -520.5% | |
| Annual Net Income | -$187.50M | +65.6% | +89.3% | -41.3% | -388.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$183.47M | at high | |
| 5Y | -$183.47M | at high | |
| All | -$4.18M | -4285.1% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$615.68M | N/A | +70.2% |
| 5Y | -$1.67B | +89.0% | |
| All | -$1.67B | +89.0% |
EBITDA History
FAQ
What is the current annual EBITDA of NVAX?
As of today, NVAX annual EBITDA is -$183.47M
What is 1-year change in NVAX annual EBITDA?
NVAX annual EBITDA is up +50.92% year-over-year
What is 3-year change in NVAX annual EBITDA?
NVAX annual EBITDA is up +89.04% over the past 3 years
How far is NVAX annual EBITDA from its all-time high?
NVAX annual EBITDA is currently -4285.13% below its historical high of -$4.18M set on December 31, 1999
How does NVAX annual EBITDA rank versus sector peers?
NVAX annual EBITDA is higher than 9.00% of companies in Healthcare sector
When is NVAX next annual earnings release?
The next annual earnings release for NVAX is on
Quarterly EBITDA
-$72.82M$186.05M-164.31%
Summary
- Current Value
- As of today, NVAX quarterly EBITDA is -$72.82M, down -164.31% on
- Historical Performance
- NVAX quarterly EBITDA is up +37.80% year-over-year, and up +38.73% over the past 3 years
- All-Time High Comparison
- NVAX quarterly EBITDA is currently -113.89% below its historical high of $524.36M set on
- 3-Year Low Comparison
- NVAX quarterly EBITDA is +76.03% above its 3-year low of -$303.73M reached on
- Sector Comparison
- NVAX quarterly EBITDA is higher than 4.79% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$72.82M | -164.3% | +37.8% | +38.7% | +62.1% | |
| Annual EBITDA | -$183.47M | – | +50.9% | +89.0% | -48.2% | |
| TTM EBITDA | $451.74M | +10.9% | +285.8% | +137.6% | +276.5% | |
| Price | $7.78 | -12.7% | -9.0% | -36.7% | -93.9% | |
| PE Ratio | 4.40 | -12.7% | – | – | – | |
| Quarterly Revenue | $70.45M | -70.5% | -16.6% | -90.4% | -55.1% | |
| Quarterly EPS | -$1.25 | -307.4% | -64.5% | +42.1% | +61.1% | |
| Quarterly EBIT | -$79.40M | -175.1% | +38.8% | +37.6% | +58.9% | |
| Quarterly Net Income | -$202.38M | -290.0% | -66.8% | -20.0% | -2.6% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $524.36M | -113.9% | |
| 3Y | $524.36M | -113.9% | |
| 5Y | $524.36M | -113.9% | |
| All | $524.36M | -113.9% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$113.04M | N/A | +35.6% |
| 3Y | -$303.73M | +76.0% | |
| 5Y | -$821.30M | +91.1% | |
| All | -$821.30M | +91.1% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of NVAX?
As of today, NVAX quarterly EBITDA is -$72.82M
What is NVAX quarterly EBITDA most recent change?
NVAX quarterly EBITDA was down -164.31% on September 30, 2025
What is 1-year change in NVAX quarterly EBITDA?
NVAX quarterly EBITDA is up +37.80% year-over-year
How far is NVAX quarterly EBITDA from its all-time high?
NVAX quarterly EBITDA is currently -113.89% below its historical high of $524.36M set on March 31, 2025
How does NVAX quarterly EBITDA rank versus sector peers?
NVAX quarterly EBITDA is higher than 4.79% of companies in Healthcare sector
When is NVAX next earnings release?
The next earnings release for NVAX is on
TTM EBITDA
$451.74M$44.26M+10.86%
Summary
- Current Value
- As of today, NVAX TTM EBITDA is $451.74M, up +10.86% on
- Historical Performance
- NVAX TTM EBITDA is up +285.76% year-over-year, and up +137.63% over the past 3 years
- All-Time High Comparison
- NVAX TTM EBITDA is currently -3.37% below its historical high of $467.50M set on
- 3-Year Low Comparison
- NVAX TTM EBITDA is +139.81% above its 3-year low of -$1.13B reached on
- Sector Comparison
- NVAX TTM EBITDA is higher than 89.78% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $451.74M | +10.9% | +285.8% | +137.6% | +276.5% | |
| Annual EBITDA | -$183.47M | – | +50.9% | +89.0% | -48.2% | |
| Quarterly EBITDA | -$72.82M | -164.3% | +37.8% | +38.7% | +62.1% | |
| Price | $7.78 | -12.7% | -9.0% | -36.7% | -93.9% | |
| PE Ratio | 4.40 | -12.7% | – | – | – | |
| TTM Revenue | $1.06B | -1.3% | +20.3% | -42.4% | +420.0% | |
| TTM EPS | $1.77 | -21.6% | +178.3% | +110.2% | +133.9% | |
| TTM EBIT | $416.73M | +13.8% | +243.7% | +134.0% | +260.3% | |
| TTM Net Income | $341.75M | -19.2% | +220.0% | +125.8% | +225.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $467.50M | -3.4% | |
| 3Y | $467.50M | -3.4% | |
| 5Y | $467.50M | -3.4% | |
| All | $467.50M | -3.4% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$183.44M | N/A | +346.3% |
| 3Y | -$1.13B | +139.8% | |
| 5Y | -$1.67B | +127.0% | |
| All | -$1.67B | +127.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of NVAX?
As of today, NVAX TTM EBITDA is $451.74M
What is NVAX TTM EBITDA most recent change?
NVAX TTM EBITDA was up +10.86% on September 30, 2025
What is 1-year change in NVAX TTM EBITDA?
NVAX TTM EBITDA is up +285.76% year-over-year
How far is NVAX TTM EBITDA from its all-time high?
NVAX TTM EBITDA is currently -3.37% below its historical high of $467.50M set on March 31, 2025
How does NVAX TTM EBITDA rank versus sector peers?
NVAX TTM EBITDA is higher than 89.78% of companies in Healthcare sector
When is NVAX next earnings release?
The next earnings release for NVAX is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- NVAX Official Website www.novavax.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1000694/000100069425000046/0001000694-25-000046-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1000694/000100069425000004/0001000694-25-000004-index.htm
- NVAX Profile on Yahoo Finance finance.yahoo.com/quote/NVAX
- NVAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvax